Clinical Trial Update: A Trial of MitoQ for the Treatment of People With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of MitoQ for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• MitoQ

Snippet

Sponsor: Antipodean Pharmaceuticals, Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED